EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Reversal of Premature Hair Graying Treated with a Topical Formulation Containing α-Melanocyte-Stimulating Hormone Agonist (Greyverse Solution 2%)

Dipali Chavan

International Journal of Trichology · 2022-11 · 14 (6) · 207-209

DOI: 10.4103/ijt.ijt_85_22 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Trichology, 2022-11. Verfasst von Dipali Chavan. Beteiligte Einrichtung: Skin Central, Deccan, Pune, Maharashtra, India. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With aging, hair graying is a common sign resulting from complex regulation of melanogenesis. Multiple factors control the stimulation of melanogenesis at the level of the hair follicle, including melanin-stimulating hormone (MSH), adrenocorticotropic hormone, endothelin-1, prostaglandins, leukotrienes, neutrophils, fibroblast growth factor, nitric oxide, catecholamines, Vitamins, and minerals. Premature hair graying (PHG) has a major impact on the cosmesis, self-credibility, and social life of the affected individual. Currently, there is no medical treatment available for PHG. We present a case of a 25-year-old female with a history of graying of hair on the scalp. Clinical diagnosis revealed it as a case of premature graying/canities. She was prescribed a topical formulation (Greyverse solution) containing palmitoyl tetrapeptide 20, a biomimetic biopeptide of α -MSH for treating her PHG. The formulation was applied 1 mL twice daily directly on the affected part of the scalp. Hair supplements containing a combination of biotin and calcium pantothenate once daily orally were also prescribed. After 3 months, the patient showed some improvement, and the dose of the topical solution was reduced to 1 mL once daily. After 5 months, the patient achieved >90% conversion of gray hair to black hair.

Schlagwörter

Stichwörter der Autor:innen

Greyversemelanocyte-stimulating hormonemelanogenesispremature hair graying

Autor:innen und Institutionen

  • Skin Central, Deccan, Pune, Maharashtra, India.

Zitieren

APA

Chavan, D. (2022). Reversal of Premature Hair Graying Treated with a Topical Formulation Containing α-Melanocyte-Stimulating Hormone Agonist (Greyverse Solution 2%). International Journal of Trichology, 14(6), 207-209. https://doi.org/10.4103/ijt.ijt_85_22

Vancouver

Chavan D. Reversal of Premature Hair Graying Treated with a Topical Formulation Containing α-Melanocyte-Stimulating Hormone Agonist (Greyverse Solution 2%). International Journal of Trichology. 2022;14(6):207-209. doi:10.4103/ijt.ijt_85_22

BibTeX
@article{Chavan2022,
  author = {Chavan, Dipali},
  title = {Reversal of Premature Hair Graying Treated with a Topical Formulation Containing α-Melanocyte-Stimulating Hormone Agonist (Greyverse Solution 2%)},
  journal = {International Journal of Trichology},
  year = {2022},
  volume = {14},
  number = {6},
  pages = {207--209},
  doi = {10.4103/ijt.ijt_85_22}
}
Kostenlos starten →